Madrona Venture Group, LLC
CIK
1887785
Location
SEATTLE, WA
Portfolio Value
Micro
$22,052,854
Diversification
Highly concentrated
Filing Date
Global Rank
#7,757
/ 8,662
▼ 279
· as of Dec 2025
Top Industry
Biotechnology
54.8%
3Y Alpha vs SPY
-15.4%
Period ended 6 months ago
Filed Feb 13, 2026 · 5mo
21 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+17.1%
SPY
+76.0%
Annualised alpha
-15.3%
Max drawdown
−53.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
3 positions · as of Dec 31, 2025 · Δ vs Sep 30, 2025Top Position
53.2%
−5.5 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
4,877
Highly concentrated+52
Portfolio Trend
21 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 54.8% | $12,093,094 |
| Technology | 45.2% | $9,959,760 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
3 positions ·
$22,052,854 total
· as of Dec 31, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NAUT |
Nautilus Biotechnology, Inc.
Healthcare
|
Held | 6,020,770 | $11,740,501 | 53.24% | |
| PATH |
UiPath, Inc.
Technology
|
Held | 607,673 | $9,959,760 | 45.16% | |
| DNA |
Ginkgo Bioworks Holdings, Inc.
Healthcare
|
Held | 42,430 | $352,593 | 1.60% |